4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-002550
Options or other derivatives
- Chief Business Officer acquired 45,850 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Linscott Walt Addison Chief Business Officer | 2022-01-26 | Grant or award · Stock Option (right to buy) | +45,850 | 45,850 | D | ||
Loading xslF345X03/ownership.xml…